AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.06B
NBNCX
Price
$14.70
Change
-$0.07 (-0.47%)
Updated
Oct 17 closing price
Net Assets
246.94M
Interact to see
Advertisement

AEPCX vs NBNCX

Header iconAEPCX vs NBNCX Comparison
Open Charts AEPCX vs NBNCXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.06B
Neuberger Berman International Sel C
Price$14.70
Change-$0.07 (-0.47%)
VolumeN/A
Net Assets246.94M
AEPCX vs NBNCX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. NBNCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and NBNCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. NBNCX (247M). AEPCX pays higher dividends than NBNCX: AEPCX (0.16) vs NBNCX (0.06). AEPCX was incepted earlier than NBNCX: AEPCX (25 years) vs NBNCX (18 years). NBNCX (2.13) is less costly to investors than AEPCX (1.57). NBNCX is a more actively managed with annual turnover of: 69.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than NBNCX: AEPCX (250) vs NBNCX (1000). AEPCX annual gain was more profitable for investors over the last year : 10.02 vs. NBNCX (7.30). AEPCX return over 5 years is better than : 9.92 vs. NBNCX (9.21).
AEPCXNBNCXAEPCX / NBNCX
Total Expense Ratio1.571.9182%
Annual Report Gross Expense Ratio1.572.1374%
Fund Existence25 years18 years-
Gain YTD20.63116.759123%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets137B247M55,466%
Annual Yield % from dividends0.160.06242%
Returns for 1 year10.027.30137%
Returns for 3 years45.8540.77112%
Returns for 5 years9.929.21108%
Returns for 10 years36.7641.5988%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp